Date d’effet: 2026-09-20 · Version: v1.1
Research, Medical and AI Disclaimer
Les informations de recherche et sorties générées ne sont pas des conseils médicaux et doivent être vérifiées.
Exploitant: Celiums Solutions, LLC
Research information only
OncoRadar is an oncology research discovery and organization service. Content is informational and may omit studies, updates, retractions, corrections or context. Ranking and retrieval relevance do not establish scientific quality, clinical validity or consensus.
Not medical advice
Nothing in OncoRadar is medical, nursing, pharmacy, diagnostic, treatment or emergency advice. It does not create a clinician-patient relationship. Patients and caregivers should consult qualified professionals; emergencies require local emergency services. Professionals remain responsible for independent clinical judgment and applicable standards.
No patient or PHI data
Do not enter PHI, patient data, case narratives that identify a person, medical record numbers, direct identifiers, or data intended to support a specific patient's care. OncoRadar is not configured or offered as a HIPAA-compliant clinical data service, and no business associate relationship is created by these documents.
Generated output limitations
Generative systems can hallucinate, conflate evidence, miss qualifiers, repeat bias, produce non-unique text or cite a source incorrectly. Always open authoritative sources, confirm quotations and licenses, inspect methods and statistics, and obtain appropriate expert review before publication or action.
Models and retrieval
The current implementation can use Qwen for embeddings, Hyphae as open-source data-plane technology for indexing and retrieval, and Gemma through Amazon Bedrock Mantle for synthesis. Model names describe technology, not endorsement or operation of OncoRadar by their providers.
No guaranteed completeness
Availability, source coverage, indexing, model behavior and links change. OncoRadar does not guarantee that any output is complete, current, safe, non-infringing or suitable for a specific research protocol, regulatory submission or clinical purpose.